V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006822 | 300004905 | 1.63 | 65 | Not known (9) | 2016-01-24 | 2016-02-24 | Trial Unspecified | Y | N | 300023507 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300006823 | 300004906 | null | 77.2 | Curative (C) | 2018-05-30 | 2018-07-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300023542 | BEVACIZUMAB |
| 300006824 | 300004907 | 1.61 | 48.8 | Palliative (P) | 2013-12-17 | 2014-01-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 300023549 | NOT MATCHED |
| 300006825 | 300004907 | 1.76 | 163 | null | 2018-01-08 | 2018-01-25 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 300023549 | CARBOPLATIN + RT |
| 300006826 | 300004908 | null | 69.8 | Palliative (P) | 2015-06-14 | 2015-07-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300023558 | TRIAL |
| 300006827 | 300004910 | 1.77 | 70 | Adjuvant (A) | 2014-03-08 | 2014-03-08 | CETUXIMAB | Y | null | 300023568 | FLUOROURACIL |
| 300006828 | 300004910 | null | null | Palliative (P) | 2014-12-09 | 2015-05-08 | Trial Unspecified | 02 | null | 300023568 | CISPLATIN + FLUOROURACIL |
| 300006829 | 300004911 | 1.81 | 112.1 | Curative (C) | 2017-10-19 | 2017-10-19 | CAV | N | null | 300023584 | CARBOPLATIN + RT |
| 300006830 | 300004912 | 1.74 | 80 | null | 2014-08-28 | 2014-08-28 | Oxaliplatin + Modified de Gramont | N | N | 300023593 | EVEROLIMUS |
| 300006831 | 300004912 | null | 75.8 | Palliative (P) | null | 2016-04-28 | NIVOLUMAB | 2 | N | 300023593 | TEYSUNO |
| 300006832 | 300004913 | 1.65 | 63.4 | Palliative (P) | 2016-12-03 | 2016-12-10 | Trial Unspecified | N | N | 300023608 | CARBOPLATIN |
| 300006835 | 300004916 | 1.73 | 77 | Curative (C) | 2015-04-08 | 2015-04-16 | Folfirinox | N | N | 300023651 | CISPLATIN + FLUOROURACIL |
| 300006836 | 300007039 | 1.52 | 73.5 | Palliative (P) | 2014-05-21 | 2014-05-27 | Capecitabine + Mitomycin | N | N | 300023653 | TOPOTECAN |
| 300006837 | 300004917 | 1.58 | 56.9 | Curative (C) | 2016-01-23 | 2016-01-24 | Carboplatin AUC 2 - 5 | N | N | 300023703 | TRIAL |
| 300006838 | 300004920 | 1.77 | 60 | Curative (C) | 2016-09-08 | 2016-10-01 | Gemcitabine + Capecitabine | 02 | N | 300023705 | CISPLATIN + FLUOROURACIL |
| 300006839 | 300004920 | 1.53 | 95 | Curative (C) | 2015-02-26 | 2015-02-27 | Cetuximab 7 day (>Cycle 2) | N | Y | 300023705 | CISPLATIN + FLUOROURACIL + RT |
| 300006840 | 300004920 | 1.65 | null | null | 2014-12-05 | 2014-12-23 | Hydroxycarbamide | N | N | 300023705 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006841 | 300004920 | null | 74.5 | Curative (C) | 2016-01-13 | 2016-04-13 | DE-ESCALATE TRIAL | null | null | 300023705 | CETUXIMAB + RT |
| 300006842 | 300004920 | null | 54 | Curative (C) | 2014-08-12 | 2015-01-06 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 300023705 | CARBOPLATIN |
| 300006843 | 300004921 | 1.62 | 90.7 | Palliative (P) | 2013-09-07 | 2013-09-12 | ECX | Y | N | 300023818 | TRIAL |
| 300006845 | 300004923 | 1.79 | 40 | Curative (C) | 2016-07-23 | 2016-09-03 | CARBOPLATIN + PACLITAXEL | 2 | N | 300023846 | TRIAL |
| 300006846 | 300004924 | 1.74 | 63 | Disease modification (D) | 2015-06-23 | 2015-07-08 | FLUOROURACIL + OXALIPLATIN | 2 | N | 300023863 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006847 | 300004925 | 1.49 | 58 | Curative (C) | 2013-03-27 | 2013-04-26 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300023868 | CISPLATIN + ETOPOSIDE |
| 300006848 | 300004925 | 1.75 | 71 | Palliative (P) | 2013-11-12 | 2015-01-13 | Cetuximab 7 day (Cycle 1) | 2 | N | 300023868 | CAPECITABINE + OXALIPLATIN |
| 300006849 | 300004925 | 1.58 | 82.1 | Adjuvant (A) | null | 2017-11-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | 300023868 | CETUXIMAB |
| 300006850 | 300004928 | 1.74 | 74.7 | Palliative (P) | 2016-11-16 | 2016-12-04 | Gemcitabine + Capecitabine | N | N | 300023919 | CARBOPLATIN + PACLITAXEL |
| 300006851 | 300004929 | 1.6 | 64.5 | Adjuvant (A) | 2014-11-15 | 2014-11-16 | Oxaliplatin + Modified de Gramont | 2 | N | 300023919 | CETUXIMAB + CISPLATIN + FU |
| 300006852 | 300004930 | 1.67 | 94.2 | Palliative (P) | 2017-02-20 | 2017-03-03 | CETUXIMAB + RT | 02 | N | 300023934 | CARBOPLATIN |
| 300006853 | 300004932 | 1.64 | 43.4 | Palliative (P) | null | 2015-01-26 | Irinotecan + Modified De Gramont | N | N | 300023938 | TRIAL |
| 300006858 | 300004936 | null | null | Curative (C) | null | 2016-05-08 | Cetuximab + Radiotherapy Load | null | null | 300023954 | TRIAL |
| 300006859 | 300004936 | 1.59 | 61.9 | Palliative (P) | 2014-05-01 | 2014-05-18 | Trial Unspecified | 2 | N | 300023954 | GEMCITABINE + OXALIPLATIN |
| 300006860 | 300004936 | 1.7 | 50.6 | Curative (C) | 2013-12-03 | 2013-12-03 | Cetuximab + Radiotherapy Load | 2 | Y | 300023954 | CISPLATIN |
| 300006861 | 300004938 | 1.64 | 94.1 | Curative (C) | 2014-01-12 | 2014-01-14 | Carboplatin AUC 6 - 10 | 02 | null | 300023964 | KESTREL TRIAL |
| 300006862 | 300004938 | 1.7 | 44.6 | Palliative (P) | 2013-05-20 | 2013-07-29 | Trial Unspecified | 02 | N | 300023964 | CISPLATIN + FLUOROURACIL |
| 300006863 | 300004939 | null | 89 | Adjuvant (A) | 2016-04-14 | 2016-04-15 | Oxaliplatin + Modified de Gramont | N | N | 300024019 | CISPLATIN |
| 300006864 | 300004940 | null | null | Curative (C) | 2017-10-11 | 2017-10-11 | Carboplatin AUC 2 - 5 | 2 | N | 300024022 | GEMCARBO |
| 300006865 | 300004940 | null | 80.4 | Palliative (P) | null | 2018-08-08 | CHOP R - 21 days | Y | N | 300024022 | NILOTINIB |
| 300006866 | 300004941 | null | 86.4 | Palliative (P) | 2018-03-18 | 2018-03-22 | Docetaxel 75mg/m2 (21 day) | N | N | 300024034 | CARBOPLATIN + CETUXIMAB + FU |
| 300006869 | 300004943 | null | null | Curative (C) | 2013-04-14 | 2013-05-16 | Cisplatin | N | Y | 300024116 | CISPLATIN + FLUOROURACIL + RT |
| 300006870 | 300004944 | 1.67 | 54.6 | Neo-adjuvant (N) | 2017-10-14 | 2017-10-19 | Capecitabine | 02 | N | 300024119 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006871 | 300004945 | 1.55 | 0 | Adjuvant (A) | 2013-12-03 | 2013-12-16 | Oxaliplatin + Modified de Gramont | 2 | N | 300024126 | CISPLATIN + FLUOROURACIL |
| 300006872 | 300004946 | null | 87 | Palliative (P) | 2016-04-08 | 2016-04-15 | Gemcitabine + Capecitabine | N | null | 300024152 | OXALIPLATIN |
| 300006873 | 300004946 | 1.66 | null | Curative (C) | 2014-11-15 | 2014-11-15 | Cetuximab 7 day (>Cycle 2) | N | Y | 300024152 | CARBOPLATIN + RT |
| 300006874 | 300004947 | 1.62 | 74.5 | Curative (C) | 2017-09-01 | 2017-09-27 | Cetuximab + Radiotherapy Maint | N | Y | 300024208 | CARBOPLATIN + RT |
| 300006875 | 300004948 | 1.57 | 43.6 | Palliative (P) | 2017-05-19 | 2017-05-20 | Irinotecan + Modified De Gramont | 2 | N | 300024212 | NIVOLUMAB |
| 300006876 | 300004949 | 1.8 | 52 | null | 2014-02-25 | 2014-03-03 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300024212 | CETUXIMAB |
| 300006882 | 300004955 | 1.59 | 69.8 | Palliative (P) | 2016-03-14 | 2016-05-09 | CISPLATIN + FLUOROURACIL | N | null | 300024289 | ESPAC TRIAL |
| 300006883 | 300004956 | 1.6 | 82.4 | Palliative (P) | 2014-08-18 | 2014-08-27 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 300024299 | CARBOPLATIN + ETOPOSIDE |
| 300006884 | 300004957 | 1.65 | 108 | Adjuvant (A) | 2016-11-19 | 2016-11-19 | Gemcitabine + Capecitabine | N | N | 300024300 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 300006885 | 300004958 | 1.58 | 90.6 | Curative (C) | 2013-09-03 | 2013-10-06 | Cetuximab + Radiotherapy Load | null | Y | 300024303 | CISPLATIN + FLUOROURACIL |